课题基金 / 基金详情

Involovement of p16 tumor suppressor gene in cell cycle progression

Involovement of p16 tumor suppressor gene in cell cycle progression
p16 抑癌基因参与细胞周期进程
批准号:
07671773
负责人:
YOKOYAMA Yasuhiro
金额:
$1.54万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1995
资助国家:
日本
项目状态:
已结题
起止时间:
1995 至 1996

项目摘要

项目成果

YOKOYAMA Yasuhiro的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We first studies the expression of p21 and p16 in HeLa cell, a epidermoid carcinoma cells of the cervix, Ishikawa cell, a endometrial carcinoma cells, and 2780 cell, an ovarian epithelial carcinoma cell. All three cell lines steadily express mRNA and protein of p21 and p16. The expression levels of these cell lines, however, were relatively weak. Sequence analysis of p21 and p16 of these cell lines revealed that p16 and p21 of all cell line were wild types, though codon 31 of p21 mRNA of Ishikawa cell was arginine polymorphism. Next, p53 gene of 2780 was studied by using sequence analysis, showing deletion in its codon 178. The p53 of HeLA cells is inactivated by E6 protein of papilloma virus type 18. Therefore we supposed that p21 of these cell lines was independent of p53 and gene transfer of p21 into these two cell line may make a sense. We subcloned p21 gene into pMAMneo, a eucaryotic expression vector and pXT1 a retroviral vector and introduced into these cell lines. After G418 selection, we obtained sublines of HeLa and 2780 cells. These sublines showed apparent retardation of cell growth and attenuated telomerase activity. Cell cycle analysis using flowcytometry showed that the blockage from G0G1 to S is major cause of cell growth retardation. These results suggest that introduction of p21 gene into carcinoma cells of which p53 is inactivated by viral oncoproteins will suppress cell growth more efficiently than p53 itself.
期刊论文(11)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Yokoyama Y.et al.: "Immunohistochemical study of estradiol, epidermal growth factor, transfeorming growth factor alpha and epidermal growth factor receptor." Jpn.J.Clin.Oncol. 26. 411-416 (1997)
Yokoyama Y.等人:“雌二醇、表皮生长因子、转化生长因子α和表皮生长因子受体的免疫组织化学研究。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
高橋雄一郎: "サイクリンインヒビターを用いた遺伝子治療に関する基礎的検討" 日本癌学会総会記事. 188-188 (1995)
Yuichiro Takahashi:“使用细胞周期蛋白抑制剂进行基因治疗的基础研究”,日本癌症协会大会上的文章188-188(1995)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
11
    Involvement of PTEN in hormone-dependent proliferation of endometrial ocarcinoma cells
    • 批准号:
      14571552
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      2002
    • 负责人:
      YOKOYAMA Yasuhiro
    • 依托单位:
    Gene therapy with hammerhead ribozymes targeting telomerase components in the endometrial carcinoma.
    • 批准号:
      10671528
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.15万
    • 财政年份:
      1998
    • 负责人:
      YOKOYAMA Yasuhiro
    • 依托单位:
    国内基金
    海外基金
    靶向调控Bmi-1/P16Ink4α信号途径介导喉癌细胞高增殖亚群早熟衰老及化疗增敏的实验研究
    • 批准号:
      30973288
    • 项目类别:
      面上项目
    • 资助金额:
      30.0万元
    • 批准年份:
      2009
    • 负责人:
      金春顺
    • 依托单位:
    P16INK4和P15INK4B与人原发性肝癌的演变与逆转研究
    • 批准号:
      39670702
    • 项目类别:
      面上项目
    • 资助金额:
      10.0万元
    • 批准年份:
      1996
    • 负责人:
      覃扬
    • 依托单位:
    CDKN2基因突变对P16INK4蛋白功能的影响